Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-01

Clinical Trial Update: Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD [NA]

View source ↗

Summary

A completed randomized double-blind clinical trial evaluating neurofeedback for attention-deficit/hyperactivity disorder has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neurofeedback

Snippet

Sponsor: Ohio State University | Conditions: Attention-Deficit/Hyperactivity Disorder | NA | Status: COMPLETED | Results posted: 2020-09-01